Quantum-Si (QSI) Competitors

$0.91 -0.07 (-7.55%)

Closing price 04:00 PM Eastern

Extended Trading

$0.91 +0.00 (+0.26%)

As of 07:58 PM Eastern

QSI vs. TRNS, CTKB, FEIM, LAB, and NAUT

Should you be buying Quantum-Si stock or one of its competitors? The main competitors of Quantum-Si include Transcat (TRNS), Cytek Biosciences (CTKB), Frequency Electronics (FEIM), Standard BioTools (LAB), and Nautilus Biotechnology (NAUT). These companies are all part of the "measuring and control equipment" industry.

How does Quantum-Si compare to Transcat?

Quantum-Si (NASDAQ:QSI) and Transcat (NASDAQ:TRNS) are both small-cap computer and technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, media sentiment, analyst recommendations, dividends, risk, valuation, earnings and institutional ownership.

In the previous week, Quantum-Si had 3 more articles in the media than Transcat. MarketBeat recorded 5 mentions for Quantum-Si and 2 mentions for Transcat. Transcat's average media sentiment score of 1.19 beat Quantum-Si's score of 0.33 indicating that Transcat is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Quantum-Si	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Transcat	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Transcat has a net margin of 2.47% compared to Quantum-Si's net margin of -4,160.06%. Transcat's return on equity of 6.15% beat Quantum-Si's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Quantum-Si	-4,160.06%	-43.90%	-39.30%
Transcat	2.47%	6.15%	4.15%

Quantum-Si currently has a consensus price target of $3.25, suggesting a potential upside of 258.48%. Transcat has a consensus price target of $105.33, suggesting a potential upside of 38.14%. Given Quantum-Si's higher possible upside, equities analysts clearly believe Quantum-Si is more favorable than Transcat.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Quantum-Si	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Transcat	2 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.40

Transcat has higher revenue and earnings than Quantum-Si. Quantum-Si is trading at a lower price-to-earnings ratio than Transcat, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Quantum-Si	$2.44M	80.39	-$101.34M	-$0.52	N/A
Transcat	$319.69M	2.23	$14.52M	$0.85	89.71

Quantum-Si has a beta of 3.15, meaning that its stock price is 215% more volatile than the S&P 500. Comparatively, Transcat has a beta of 0.68, meaning that its stock price is 32% less volatile than the S&P 500.

39.9% of Quantum-Si shares are held by institutional investors. Comparatively, 98.3% of Transcat shares are held by institutional investors. 22.0% of Quantum-Si shares are held by insiders. Comparatively, 2.8% of Transcat shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

Transcat beats Quantum-Si on 11 of the 16 factors compared between the two stocks.

How does Quantum-Si compare to Cytek Biosciences?

Quantum-Si (NASDAQ:QSI) and Cytek Biosciences (NASDAQ:CTKB) are both small-cap measuring and control equipment companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, institutional ownership, media sentiment, earnings, profitability and dividends.

Quantum-Si currently has a consensus price target of $3.25, suggesting a potential upside of 258.48%. Cytek Biosciences has a consensus price target of $5.38, suggesting a potential upside of 16.59%. Given Quantum-Si's stronger consensus rating and higher possible upside, analysts clearly believe Quantum-Si is more favorable than Cytek Biosciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Quantum-Si	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Cytek Biosciences	2 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.00

Quantum-Si has a beta of 3.15, suggesting that its stock price is 215% more volatile than the S&P 500. Comparatively, Cytek Biosciences has a beta of 1.22, suggesting that its stock price is 22% more volatile than the S&P 500.

In the previous week, Cytek Biosciences had 2 more articles in the media than Quantum-Si. MarketBeat recorded 7 mentions for Cytek Biosciences and 5 mentions for Quantum-Si. Quantum-Si's average media sentiment score of 0.33 beat Cytek Biosciences' score of -0.27 indicating that Quantum-Si is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Quantum-Si	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Cytek Biosciences	1 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Cytek Biosciences has a net margin of -33.02% compared to Quantum-Si's net margin of -4,160.06%. Cytek Biosciences' return on equity of -7.70% beat Quantum-Si's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Quantum-Si	-4,160.06%	-43.90%	-39.30%
Cytek Biosciences	-33.02%	-7.70%	-5.89%

39.9% of Quantum-Si shares are held by institutional investors. Comparatively, 69.5% of Cytek Biosciences shares are held by institutional investors. 22.0% of Quantum-Si shares are held by insiders. Comparatively, 10.3% of Cytek Biosciences shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Cytek Biosciences has higher revenue and earnings than Quantum-Si. Cytek Biosciences is trading at a lower price-to-earnings ratio than Quantum-Si, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Quantum-Si	$2.44M	80.39	-$101.34M	-$0.52	N/A
Cytek Biosciences	$201.49M	2.95	-$66.54M	-$0.51	N/A

Summary

Cytek Biosciences beats Quantum-Si on 8 of the 15 factors compared between the two stocks.

How does Quantum-Si compare to Frequency Electronics?

Quantum-Si (NASDAQ:QSI) and Frequency Electronics (NASDAQ:FEIM) are both small-cap computer and technology companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, valuation, media sentiment, earnings, analyst recommendations, risk, institutional ownership and dividends.

Frequency Electronics has a net margin of 10.78% compared to Quantum-Si's net margin of -4,160.06%. Frequency Electronics' return on equity of 12.69% beat Quantum-Si's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Quantum-Si	-4,160.06%	-43.90%	-39.30%
Frequency Electronics	10.78%	12.69%	7.84%

Frequency Electronics has higher revenue and earnings than Quantum-Si. Quantum-Si is trading at a lower price-to-earnings ratio than Frequency Electronics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Quantum-Si	$2.44M	80.39	-$101.34M	-$0.52	N/A
Frequency Electronics	$67.82M	9.05	$23.69M	$0.75	83.17

39.9% of Quantum-Si shares are held by institutional investors. Comparatively, 58.6% of Frequency Electronics shares are held by institutional investors. 22.0% of Quantum-Si shares are held by insiders. Comparatively, 28.0% of Frequency Electronics shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Quantum-Si has a beta of 3.15, meaning that its share price is 215% more volatile than the S&P 500. Comparatively, Frequency Electronics has a beta of 0.53, meaning that its share price is 47% less volatile than the S&P 500.

Quantum-Si presently has a consensus price target of $3.25, suggesting a potential upside of 258.48%. Frequency Electronics has a consensus price target of $43.67, suggesting a potential downside of 30.00%. Given Quantum-Si's higher possible upside, equities research analysts clearly believe Quantum-Si is more favorable than Frequency Electronics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Quantum-Si	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Frequency Electronics	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	3.00

In the previous week, Frequency Electronics had 4 more articles in the media than Quantum-Si. MarketBeat recorded 9 mentions for Frequency Electronics and 5 mentions for Quantum-Si. Frequency Electronics' average media sentiment score of 0.99 beat Quantum-Si's score of 0.33 indicating that Frequency Electronics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Quantum-Si	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Frequency Electronics	4 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Frequency Electronics beats Quantum-Si on 13 of the 17 factors compared between the two stocks.

How does Quantum-Si compare to Standard BioTools?

Standard BioTools (NASDAQ:LAB) and Quantum-Si (NASDAQ:QSI) are both small-cap measuring and control equipment companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, media sentiment, profitability, earnings and valuation.

In the previous week, Quantum-Si had 1 more articles in the media than Standard BioTools. MarketBeat recorded 5 mentions for Quantum-Si and 4 mentions for Standard BioTools. Standard BioTools' average media sentiment score of 0.35 beat Quantum-Si's score of 0.33 indicating that Standard BioTools is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Standard BioTools	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Quantum-Si	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Standard BioTools has a beta of 1.32, meaning that its share price is 32% more volatile than the S&P 500. Comparatively, Quantum-Si has a beta of 3.15, meaning that its share price is 215% more volatile than the S&P 500.

53.7% of Standard BioTools shares are owned by institutional investors. Comparatively, 39.9% of Quantum-Si shares are owned by institutional investors. 23.2% of Standard BioTools shares are owned by company insiders. Comparatively, 22.0% of Quantum-Si shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Standard BioTools currently has a consensus price target of $1.35, indicating a potential upside of 32.35%. Quantum-Si has a consensus price target of $3.25, indicating a potential upside of 258.48%. Given Quantum-Si's stronger consensus rating and higher possible upside, analysts clearly believe Quantum-Si is more favorable than Standard BioTools.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Standard BioTools	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67
Quantum-Si	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

Standard BioTools has higher revenue and earnings than Quantum-Si. Quantum-Si is trading at a lower price-to-earnings ratio than Standard BioTools, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Standard BioTools	$85.33M	4.67	-$74.90M	$0.20	5.10
Quantum-Si	$2.44M	80.39	-$101.34M	-$0.52	N/A

Standard BioTools has a net margin of 73.46% compared to Quantum-Si's net margin of -4,160.06%. Standard BioTools' return on equity of -8.89% beat Quantum-Si's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Standard BioTools	73.46%	-8.89%	-6.67%
Quantum-Si	-4,160.06%	-43.90%	-39.30%

Summary

Standard BioTools beats Quantum-Si on 10 of the 16 factors compared between the two stocks.

How does Quantum-Si compare to Nautilus Biotechnology?

Quantum-Si (NASDAQ:QSI) and Nautilus Biotechnology (NASDAQ:NAUT) are both small-cap measuring and control equipment companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, valuation, dividends, institutional ownership, risk, earnings, analyst recommendations and media sentiment.

Nautilus Biotechnology has a net margin of 0.00% compared to Quantum-Si's net margin of -4,160.06%. Nautilus Biotechnology's return on equity of -35.04% beat Quantum-Si's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Quantum-Si	-4,160.06%	-43.90%	-39.30%
Nautilus Biotechnology	N/A	-35.04%	-29.16%

Quantum-Si presently has a consensus price target of $3.25, indicating a potential upside of 258.48%. Nautilus Biotechnology has a consensus price target of $4.00, indicating a potential upside of 49.25%. Given Quantum-Si's stronger consensus rating and higher probable upside, equities analysts clearly believe Quantum-Si is more favorable than Nautilus Biotechnology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Quantum-Si	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Nautilus Biotechnology	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Nautilus Biotechnology has lower revenue, but higher earnings than Quantum-Si. Nautilus Biotechnology is trading at a lower price-to-earnings ratio than Quantum-Si, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Quantum-Si	$2.44M	80.39	-$101.34M	-$0.52	N/A
Nautilus Biotechnology	N/A	N/A	-$59M	-$0.46	N/A

In the previous week, Quantum-Si had 4 more articles in the media than Nautilus Biotechnology. MarketBeat recorded 5 mentions for Quantum-Si and 1 mentions for Nautilus Biotechnology. Nautilus Biotechnology's average media sentiment score of 0.80 beat Quantum-Si's score of 0.33 indicating that Nautilus Biotechnology is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Quantum-Si	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Nautilus Biotechnology	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

39.9% of Quantum-Si shares are held by institutional investors. Comparatively, 50.7% of Nautilus Biotechnology shares are held by institutional investors. 22.0% of Quantum-Si shares are held by insiders. Comparatively, 41.1% of Nautilus Biotechnology shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Quantum-Si has a beta of 3.15, meaning that its share price is 215% more volatile than the S&P 500. Comparatively, Nautilus Biotechnology has a beta of 0.75, meaning that its share price is 25% less volatile than the S&P 500.

Summary

Nautilus Biotechnology beats Quantum-Si on 8 of the 15 factors compared between the two stocks.

Get Quantum-Si News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding QSI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

QSI vs. The Competition

Export

Metric	Quantum-Si	ELEC COMP Industry	Computer Sector	NASDAQ Exchange
Market Cap	$196.16M	$67.29B	$38.74B	$12.27B
Dividend Yield	N/A	1.33%	3.16%	5.24%
P/E Ratio	-1.74	80.38	74.02	27.27
Price / Sales	80.39	121.17	622.17	64.09
Price / Cash	N/A	263.56	46.83	53.97
Price / Book	0.89	9.10	9.53	6.83
Net Income	-$101.34M	$861.73M	$1.03B	$332.87M
7 Day Performance	N/A	N/A	N/A	0.09%
1 Month Performance	20.80%	45.05%	15.00%	7.37%
1 Year Performance	-31.83%	316.08%	171.22%	41.09%

Quantum-Si Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
QSI Quantum-Si	3.711 of 5 stars	$0.91 -7.5%	$3.25 +258.5%	-18.3%	$196.16M	$2.44M	N/A	150	News Coverage Earnings Report High Trading Volume
TRNS Transcat	2.4711 of 5 stars	$70.57 -2.7%	$105.33 +49.3%	-0.2%	$676.68M	$278.42M	83.02	1,245	Positive News
CTKB Cytek Biosciences	1.1398 of 5 stars	$4.66 +0.9%	$5.38 +15.3%	+31.9%	$596.64M	$201.49M	N/A	500	News Coverage Earnings Report
FEIM Frequency Electronics	1.0767 of 5 stars	$52.94 -8.0%	$43.67 -17.5%	+220.7%	$566.21M	$69.81M	70.59	200	Analyst Upgrade
LAB Standard BioTools	3.6409 of 5 stars	$0.94 -0.1%	$1.35 +44.4%	-1.5%	$365.19M	$85.33M	N/A	620	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:QSI) was last updated on 5/8/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Quantum-Si (QSI) Competitors

QSI vs. TRNS, CTKB, FEIM, LAB, and NAUT

How does Quantum-Si compare to Transcat?

Summary

How does Quantum-Si compare to Cytek Biosciences?

Summary

How does Quantum-Si compare to Frequency Electronics?

Summary

How does Quantum-Si compare to Standard BioTools?

Summary

How does Quantum-Si compare to Nautilus Biotechnology?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

QSI vs. The Competition

Quantum-Si Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Quantum-Si (QSI) Competitors

QSI vs. TRNS, CTKB, FEIM, LAB, and NAUT

How does Quantum-Si compare to Transcat?

Does the media prefer QSI or TRNS?

Is QSI or TRNS more profitable?

Do analysts rate QSI or TRNS?

Which has preferable valuation and earnings, QSI or TRNS?

Which has more risk and volatility, QSI or TRNS?

Do institutionals and insiders have more ownership in QSI or TRNS?

Summary

How does Quantum-Si compare to Cytek Biosciences?

Do analysts recommend QSI or CTKB?

Which has more risk and volatility, QSI or CTKB?

Does the media prefer QSI or CTKB?

Is QSI or CTKB more profitable?

Do insiders and institutionals hold more shares of QSI or CTKB?

Which has preferable valuation and earnings, QSI or CTKB?

Summary

How does Quantum-Si compare to Frequency Electronics?

Is QSI or FEIM more profitable?

Which has preferable valuation & earnings, QSI or FEIM?

Do insiders & institutionals hold more shares of QSI or FEIM?

Which has more volatility & risk, QSI or FEIM?

Do analysts rate QSI or FEIM?

Does the media prefer QSI or FEIM?

Summary

How does Quantum-Si compare to Standard BioTools?

Does the media refer more to LAB or QSI?

Which has more risk and volatility, LAB or QSI?

Do institutionals & insiders believe in LAB or QSI?

Do analysts prefer LAB or QSI?

Which has higher earnings and valuation, LAB or QSI?

Is LAB or QSI more profitable?

Summary

How does Quantum-Si compare to Nautilus Biotechnology?

Is QSI or NAUT more profitable?

Do analysts recommend QSI or NAUT?

Which has preferable valuation & earnings, QSI or NAUT?

Does the media prefer QSI or NAUT?

Do institutionals and insiders believe in QSI or NAUT?

Which has more volatility & risk, QSI or NAUT?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

QSI vs. The Competition

Quantum-Si Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools